- Home
- GNK vs KALV Comparison
GNK vs KALV Comparison
Compare GNK & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNK | KALV |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 967.7M | 1.0B |
| IPO Year | 2005 | 2014 |
Fundamental Metrics
Financial Performance| Metric | GNK | KALV |
|---|---|---|
| Price | $23.58 | $26.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $19.00 | ★ $32.60 |
| AVG Volume (30 Days) | 312.0K | ★ 5.4M |
| Earning Date | 05-06-2026 | 07-09-2026 |
| Dividend Yield | ★ 3.90% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $342,054,000.00 | $50,000,000.00 |
| Revenue This Year | $21.15 | $185.42 |
| Revenue Next Year | $1.41 | $59.23 |
| P/E Ratio | $114.86 | ★ N/A |
| Revenue Growth | N/A | ★ 495.66 |
| 52 Week Low | $12.66 | $9.83 |
| 52 Week High | $27.25 | $26.85 |
Technical Indicators
Market Signals| Indicator | GNK | KALV |
|---|---|---|
| Relative Strength Index (RSI) | 43.78 | 74.68 |
| Support Level | $22.40 | $14.25 |
| Resistance Level | $24.25 | $26.85 |
| Average True Range (ATR) | 0.94 | 0.07 |
| MACD | -0.26 | -0.22 |
| Stochastic Oscillator | 1.99 | 71.05 |
Price Performance
Historical ComparisonAbout GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.